Company Profile
Updated: 09-DEC-09Duphar International Research
International Private company
Postbus 900, Weesp, 1380 DA, Netherlands
()294477711, 294480253 fax,
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Commercial Physical Research
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
German biotech firm Evotec has completed its purchase of a 70% stake in Indian drug discovery and development company Research Support International from DIL, formerly duphar-interfran, both based in Thane, near Mumbai, for 2.8m [euro].(Companies, technology & environment)(Brief article)
Chemistry and Industry; 9/14/2009; 687 words; ...has completed its purchase of a 70% stake in Indian drug discovery and development company Research Support International from DIL, formerly duphar-interfran, both based in Thane, near Mumbai, for 2.8m [euro]. Evotec has an option...
Evotec-RSIL Ltd announces two key library synthesis collaborations and celebrates its first full year of operations.
Biotech Week; 11/12/2008; 1133 words; ...smoking cessation. In research collaborations, Evotec...evotec.com About Research Support International Ltd (RSIL) RSIL...DIL Ltd, (formerly Duphar-Interfran Ltd...established Contract Research Organisation, offering...
OmniComm Systems, Inc. Expands Senior Management.
PR Newswire; 6/30/2000; 1208 words; ...www.dmv-international.com), a subsidiary...employment with DMV International, he served as Vice President of International Operations for Duphar where he was responsible...allows the clinical research industry the ability...
ArQule and Bayer Announce Collaboration in Combinatorial Chemistry.
PR Newswire; 10/1/1999; 1212 words; ...Committee for Research and Development. Bayer is an international, research-based group...is budgeted for research and development...Sankyo, and Solvay Duphar B.V. ArQule...S. and five international patents. ArQule...
Procept Names Dr. Nigel J. Rulewski Chief Medical Officer; Rulewski to Lead Inlicensing and Drug Development Efforts.
Business Wire; 12/2/1998; 1105 words; ...90 million annual research budget to develop and...and managed clinical research in many therapeutic...USA), and Kali-Duphar Laboratories (USA...Rulewski also has extensive international experience. As medical...Inc. is a public research and development company...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning